DocDollars

Arena Pharmaceuticals, Inc.

NY · United States · Reporting entity ID 100001136887

Total reported 2019–2025
$9.27M
#514 of 2,960 reporting companies — 0% of all reported industry payments
$71K in general payments across 27 records, plus $9.20M in research funding across 4,121 records.

How it breaks down

General payments $70,645
Research funding $9,195,213

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Arena Pharmaceuticals, Inc. reported $9.27M to US doctors and teaching hospitals from 2019 to 2025, ranking #514 of 2,960 reporting companies. 99% of that was research funding and 1% general payments such as consulting, speaking, food and travel. 27 general payment records and 4,121 research records were filed.

Common questions about Arena Pharmaceuticals, Inc.

How much has Arena Pharmaceuticals, Inc. paid US doctors?

Arena Pharmaceuticals, Inc. reported $9,265,858 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $70,645 in general payments, $9,195,213 in research funding.

How does Arena Pharmaceuticals, Inc. rank among drug and device companies?

It ranks #514 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Arena Pharmaceuticals, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.